Market: NASD |
Currency: USD
Address: 18000 Studebaker Road
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Show more
📈 The Oncology Institute, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$7.00
-
Upside/Downside from Analyst Target:
84.70%
-
Broker Call:
6
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
10-25%
-
Net Income Growth Range (1Y):
0-10%
-
Revenue Growth Range (1Y):
10-25%
-
Upcoming Earnings Date:
2025-11-13
-
EPS Estimate:
-0.12
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for The Oncology Institute, Inc.
Date | Reported EPS |
---|
2025-11-12 (estimated upcoming) | - |
2025-08-13 | -0.15 |
2024-08-13 | -0.14 |
2024-05-14 | -0.19 |
2024-03-26 | -0.16 |
2023-11-08 | 0.06 |
2023-08-08 | -0.19 |
2023-03-09 | -0.22 |
2022-11-09 | -0.88 |
📰 Related News & Research
No related articles found for "the oncology".